Welcome to another insightful episode of IDD Health Matters, hosted by Craig Escudé, MD, FAAFP, FAADM, president of IntellectAbility. In this episode, we explore pioneering approaches to healthcare for individuals with intellectual and developmental disabilities. Join us as Dr. Escude welcomes two distinguished guests from the international arena: Professor Angela Hassiotis from University College London and Dr. Rory Sheehan from King's College London.

Professor Hassiotis, a seasoned consultant psychiatrist in the NHS, delves into her groundbreaking research and clinical work aimed at personalizing interventions for aggressive challenging behaviors in adults with IDD. She shares the promising beginnings of the PETAL study in the UK, designed to offer multimodal interventions to those in need.

Dr. Sheehan discusses his role as a senior clinical lecturer and psychiatrist, focusing on patients with learning disabilities who encounter legal issues. He highlights the significance of utilizing large data sets to improve care delivery and touches upon the disparities in psychotropic medication use among the IDD population.

Together, they discuss the intricacies of the UK's National Health Service and the critical need for specialized training and capacity building in the field of intellectual disability psychiatry.

This episode not only sheds light on innovative research and clinical practices but also emphasizes the importance of incorporating lived experiences to enhance intervention strategies.

For more insights and detailed discussions on improving healthcare outcomes for the IDD community, tune into this episode of IDD Health Matters. Don't forget to check the show notes for more information and links to further resources.